Solventum Corp. (SOLV)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE
Market Cap: $15.14B
Last updated: Nov 17, 2026 at 11:05 AM ET
Solventum Corp. (SOLV) Financials: Revenue, Profit and Cash Flow
Solventum reported revenue of $8.32B for the fiscal year ended Dec 31, 2025, up 0.9% from the year before. That year, net income was $1.56B with a net margin of 18.7%, operating cash flow was $369.00M and free cash flow was -$10.00M. The quarter ended Sep 30, 2026 had revenue of $1.95B and net income of -$12.00M.
Revenue and Margins
The operating margin was 26.2% in the fiscal year ended Dec 2025, the highest of the 6 years shown. Over the 5 years to Dec 2025, revenue grew from $7.28B, a compound annual rate of 2.7%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $8.32B | +0.9% | 53.5% | 26.2% | 18.7% |
| Dec 2024 | $8.25B | +0.7% | 55.6% | 12.6% | 5.8% |
| Dec 2023 | $8.20B | +0.8% | 57.3% | 20.6% | 16.4% |
| Dec 2022 | $8.13B | -0.5% | 57.7% | 20.8% | 16.5% |
| Dec 2021 | $8.17B | +12.2% | 60.2% | 23.0% | 17.9% |
| Dec 2020 | $7.28B | N/A | 59.3% | 19.6% | 15.6% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 225.7% from the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
| Revenue | $8.32B | $8.25B | $8.20B | $8.13B | $8.17B | $7.28B |
| Cost of revenue | $3.87B | $3.66B | $3.50B | $3.44B | $3.25B | $2.97B |
| Gross profit | $4.45B | $4.59B | $4.69B | $4.70B | $4.92B | $4.32B |
| Research and development | $739.00M | $775.00M | $758.00M | $767.00M | $766.00M | $719.00M |
| Operating income | $2.18B | $1.04B | $1.69B | $1.69B | $1.88B | $1.43B |
| Net income | $1.56B | $479.00M | $1.35B | $1.34B | $1.46B | $1.14B |
| EBITDA | $2.63B | $1.53B | $2.23B | $2.27B | $2.48B | $2.03B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.95B | $2.21B | $2.01B | $2.00B | $2.10B | $2.16B | $2.07B | $2.08B | $2.08B | $2.08B | $2.02B | $2.04B |
| Gross profit | $1.06B | $1.29B | $1.10B | $1.03B | $1.14B | $1.18B | $1.11B | $1.12B | $1.17B | $1.14B | $1.17B | $1.16B |
| Operating income | $68.00M | $181.00M | $81.00M | $125.00M | $1.69B | $214.00M | $152.00M | $136.00M | $275.00M | $244.00M | $381.00M | $406.00M |
| Net income | -$12.00M | $92.00M | $13.00M | $63.00M | $1.27B | $90.00M | $137.00M | $31.00M | $122.00M | $89.00M | $237.00M | $272.00M |
Balance Sheet
As of Dec 2025, total debt of $5.04B exceeded cash and equivalents by $4.16B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
| Total assets | $14.29B | $14.46B | $13.94B | $13.59B | $14.07B | N/A |
| Current assets | $3.86B | $3.25B | $2.52B | $2.23B | $2.19B | N/A |
| Cash and equivalents | $878.00M | $762.00M | $194.00M | $61.00M | $91.00M | N/A |
| Total liabilities | $9.24B | $11.50B | $2.28B | $1.85B | $2.02B | N/A |
| Short-term debt | $0 | $200.00M | $0 | $27.00M | $29.00M | N/A |
| Long-term debt | $5.04B | $7.81B | $0 | N/A | N/A | N/A |
| Shareholder equity | $5.05B | $2.96B | $11.67B | $11.74B | $12.06B | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $14.16B | $14.24B | $14.10B | $14.29B | $13.97B | $15.07B | $14.53B | $14.46B | $14.74B | $14.58B | $14.71B | $13.94B |
| Total liabilities | $9.36B | $9.44B | $9.13B | $9.24B | $8.99B | $11.43B | $11.27B | $11.50B | $11.55B | $11.71B | $10.86B | $2.28B |
| Cash and equivalents | $451.00M | $403.00M | $561.00M | $878.00M | $1.64B | $492.00M | $534.00M | $762.00M | $772.00M | $897.00M | $996.00M | $194.00M |
| Shareholder equity | $4.80B | $4.80B | $4.97B | $5.05B | $4.99B | $3.65B | $3.26B | $2.96B | $3.19B | $2.87B | $3.85B | $11.67B |
Cash Flow
In the fiscal year ended Dec 2025, capital expenditures exceeded operating cash flow, leaving negative free cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $369.00M | $1.19B | $1.92B | $1.68B | $2.20B | $2.03B |
| Capital expenditures | $379.00M | $380.00M | $290.00M | $251.00M | $277.00M | $271.00M |
| Free cash flow | -$10.00M | $805.00M | $1.63B | $1.43B | $1.93B | $1.75B |
| Investing cash flow | $2.80B | -$380.00M | -$230.00M | -$253.00M | -$278.00M | $228.00M |
| Financing cash flow | -$3.06B | -$240.00M | -$1.55B | -$1.46B | -$1.96B | -$2.21B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $177.00M | $227.00M | -$189.00M | $95.00M | $76.00M | $169.00M | $29.00M | $219.00M | $169.00M | $355.00M | $442.00M | $547.00M |
| Capital expenditures | $80.00M | $83.00M | $84.00M | $63.00M | $97.00M | $110.00M | $109.00M | $127.00M | $93.00M | $58.00M | $102.00M | $88.00M |
| Free cash flow | $97.00M | $144.00M | -$273.00M | $32.00M | -$21.00M | $59.00M | -$80.00M | $92.00M | $76.00M | $297.00M | $340.00M | $459.00M |
Frequently Asked Questions About SOLV
What is Solventum's annual revenue?
Solventum reported revenue of $8.32B for the fiscal year ended Dec 31, 2025.
How fast is Solventum's revenue growing?
Revenue was up 0.9% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 0.8%.
Is Solventum profitable?
Yes. Solventum reported net income of $1.56B for the fiscal year ended Dec 31, 2025, with a net margin of 18.7%.
How much free cash flow does SOLV generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $369.00M minus capital expenditures of $379.00M produced free cash flow of -$10.00M.
How much debt does Solventum have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $5.04B, short-term debt of $0 and cash and equivalents of $878.00M.
SOLV pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors